[Cytopathology Annual Meeting Review] Heer Medical Shines at the 24th National Cytopathology Annual Meeting

From June 12 to 14, 2026, the 24th National Cytopathology Annual Meeting of the Chinese Medical Association was successfully held in Qingdao, Shandong. The conference was organized by the Chinese Medical Association and the Pathology Branch of the Chinese Medical Association, and jointly hosted by the Shandong Medical Association, the Pathology Branch of the Shandong Medical Association, and the Qingdao Central Hospital of the University of Health and Rehabilitation Sciences.

The conference brought together authoritative experts in the field of cytopathology, conducting special presentations and typical case studies around cutting-edge technologies in the discipline, with in-depth exchanges on new technologies and achievements in the industry, jointly exploring the future development direction of cytopathology.

Integrated Solutions

During the exhibition, Heer Medical presented its fully automated digital scanning analysis system and slide scanning image analysis system, comprehensively showcasing the Fully Automated Liquid-Based Cytology Intelligent Analysis Integrated Solution.

The entire solution leverages proprietary algorithms, powerful data processing capabilities, and intelligent analysis models to build a full-dimensional, multi-level automated analysis and intelligent diagnosis platform, comprehensively covering core application scenarios such as tumor cell screening, tissue pathology diagnosis, and immunohistochemistry quantitative analysis. The solution is equipped with fully automated pipeline equipment, supporting bidirectional online operation and continuous sample loading for on-demand testing. The equipment uses natural sedimentation preparation technology, with uniform staining and flat cell distribution. A single device can complete the full process of preparation, staining, and coverslipping of 90 samples per hour.

Heer Medical has launched a full series of liquid-based cytology automated preparation and staining equipment, forming a complete supporting solution. The product matrix includes: liquid-based cytology preparation-staining-coverslipping integrated machine (90 slides/hour), 48-slide/hour and 24-slide/hour preparation-staining integrated machines, as well as fully automated staining machines, sedimentation preparation machines, and cytocentrifuge preparation machines, meeting various sample throughput and clinical scenario requirements.

The company's self-developed fully automated digital scanner offers multiple specifications, with throughput options covering 4-slide, 24-slide, 40-slide, 100-slide, and 120-slide models for flexible selection. The equipment is compatible with immunohistochemistry samples, exfoliative cell samples, routine tissue samples, and other specimen types for scanning, with high color reproduction fidelity. Through multi-layer fusion scanning technology, it highly reproduces the true staining effects observed under a microscope.

The accompanying self-developed digital pathology analysis software integrates multiple core functions including pathology information management, DNA ploidy quantitative analysis, cervical cell routine cytology detection, HPV E6/E7 protein detection, and p16/Ki-67 dual-stain analysis, providing a one-stop solution for clinical diagnosis and research analysis needs.

Event Highlights

At the exhibition, Heer Medical comprehensively presented the full-chain intelligent solution for liquid-based cytology, providing reliable technical support and implementation paths for the transformation and upgrading of the domestic pathology industry with its automated, digitalized, and intelligent product system, receiving widespread attention from attending experts and peers.

Grounded in the Present, Looking to the Future

In the future, Heer Medical will continue to deepen its presence in the field of cytopathology, and continue to develop tissue pathology diagnosis and immunohistochemistry intelligent auxiliary diagnosis. We will persist in technological innovation, continuously optimize products and solutions, and assist in the high-quality development of the pathology diagnosis industry.